Mark Allen Nekola, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3990 N Illinois St, Swansea, IL 62226 Phone: 618-277-1130 Fax: 618-277-4917 |
Michael Paul Jones, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3990 N Illinois St, Swansea, IL 62226 Phone: 618-277-1130 Fax: 618-277-4917 |
Dr. Homer Ashton Ferguson Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3990 N Illinois St, Swansea, IL 62226 Phone: 618-277-1130 Fax: 618-277-4917 |
Dr. Jeffrey Michael Maher, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3990 N Illinois St, Swansea, IL 62226 Phone: 618-277-1130 Fax: 618-277-4917 |
Eric Hunt Wigton, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3990 N Illinois St, Swansea, IL 62226 Phone: 618-277-1130 Fax: 618-277-4917 |
Dr. Bart Aaron Jones, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3990 N Illinois St, Swansea, IL 62226 Phone: 618-277-1130 Fax: 618-277-4917 |
Dr. Thomas Nicholas Fleming, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3990 N Illinois St, Swansea, IL 62226 Phone: 618-277-1130 Fax: 618-277-4917 |
News Archive
CNA recognizes the importance of patient/resident safety and risk management in the evolving world of healthcare. As one of the nation's leading providers of professional liability insurance for healthcare providers and organizations, CNA HealthPro recently published a risk management toolkit, "Special Resource: Protecting Residents, Reducing Liability Exposure - An Aging Services Resource from CNA HealthPro," which offers guidance on clinical, operational, and strategic subjects of concern to aging services providers.
MEDNAX, Inc., today announced the acquisition of a maternal-fetal medicine physician group based in Wilmington, NC.
Scientists have identified where a four-stranded version of DNA exists within the genome of human cells, and suggest that it may hold a key to developing new, targeted therapies for cancer.
The Council of Canadian Academies has released three reports on requests for medical assistance in dying, the result of an independent Expert Panel review conducted at the request of the federal government. The reports were released following their tabling in Parliament today.
A new medication proved effective in slowing the spread of metastatic prostate cancer, while helping to maintain the quality of life, in patients with advanced disease. The phase 3 study was unblinded midway, allowing patients receiving the placebo to instead take the drug because of the favorable results.
› Verified 5 days ago